Skip to main content

3 Result(s)

within Pinelopi Samara Remove this filter

and

  1. No Access

    Article

    2nd Symposium on Advances in Cancer Immunology and Immunotherapy, December 15–17, 2016, Athens, Greece

    This is the 2nd Symposium of a series organized annually. It aims to integrate tumor immunology basic research with results from most recent clinical trials based on the use of anti-cancer agents targeting imm...

    Pinelopi Samara, Athanasios Kotsakis… in Cancer Immunology, Immunotherapy (2018)

  2. Article

    Open Access

    Prothymosin α and a prothymosin α-derived peptide enhance TH1-type immune responses against defined HER-2/neu epitopes

    Active cancer immunotherapies are beginning to yield clinical benefit, especially those using peptide-pulsed dendritic cells (DCs). Different adjuvants, including Toll-like receptor (TLR) agonists, commonly co...

    Kyriaki Ioannou, Evelyna Derhovanessian, Eleni Tsakiri, Pinelopi Samara… in BMC Immunology (2013)

    Download PDF (1457 KB) View Article

  3. No Access

    Article

    Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy

    The thymus is a central lymphoid organ with crucial role in generating T cells and maintaining homeostasis of the immune system. More than 30 peptides, initially referred to as “thymic hormones,” are produced ...

    Kyriaki Ioannou, Pinelopi Samara, Evangelia Livaniou… in Cancer Immunology, Immunotherapy (2012)